Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Phone-Based coaching after stroke shows promise in small trial

NCT ID NCT05940350

Symptom relief Sponsor: Akdeniz University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a telerehabilitation coaching program can help people who have had an ischemic stroke feel more confident managing their health, lower risk factors like high blood pressure and cholesterol, and avoid going back to the hospital. Sixty participants will either receive the coaching plus standard care or standard care alone. The coaching includes phone calls, videos, and goal-setting over three months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
telerehabilitation-based coaching program
What this could lead to
If successful, this approach could offer a practical way to help stroke patients manage their health at home and reduce the chance of repeat hospitalizations.
What could go wrong
This is a small, early-stage study with only 60 participants, so results may not apply to everyone. The intervention relies on patient motivation and access to technology, which may limit its effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2025

Expected to finish

Mar 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

45 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 45 years and older who had a stroke (the etiology of ischemic stroke can be seen at an earlier age due to hematological conditions, such as sickle cell anemia, polycythemia vera, factor deficiencies, vasculitis, and arterial dissection). * Comply with TOAST classification criteria * A score of "0,1,2,3" according to the Modified Rankin Scale at discharge * Place, time, person orientation * No communication barrier * Turkish-speaking writer * Having a contact phone (for phone calls) * Support can be obtained from first-degree situations) * Having no barriers to answering questions physically and mentally Exclusion Criteria: * Stroke of cryptogenic (etiology unknown) or non-vascular origin (tumor) * Have a diagnosed mental or psychiatric illness\* * With dementia and cognitive deficit\* * Clinically musculoskeletal or other neurological diseases\* * With severe aphasia and dysarthria\* * With terminal illness\* * Those who score ≥ 10 according to the LACE index * Patients whose information cannot be accessed will not be included in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coaching are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

ischemic stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Coaching Ischemic stroke

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Akdeniz University Hospital

    RECRUITING

    Antalya, 07060, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.